Hypertension remains one of the most significant and modifiable risk factors for cardiovascular disease, yet a substantial proportion of adults particularly those least engaged with routine primary care remain undiagnosed or sub optimally managed. This study presents a real-world data and findings from the London Borough of Brent, examining the population health and system level impact of deploying Microtech Health Pods as a community-based blood pressure detection and engagement intervention.
Drawing on observed screening data and conservative extrapolation, the case study demonstrates that community located hypertension detection can uncover substantial hidden cardiovascular risk, enable earlier clinical intervention, and deliver meaningful reductions in avoidable stroke, myocardial infarction, and downstream care costs. The findings position the Health Pod model as a scalable, evidence led mechanism for strengthening upstream cardiovascular prevention at population scale. The evidence demonstrates that community-located screening identifies a substantial volume of previously unmet cardiovascular risk and provides a scalable, cost-effective route to earlier clinical intervention, reduced acute events, and material NHS savings.
Using NICE aligned screening protocols, around one in five adults (20.8%) screened recorded blood pressure readings in the range indicative of Stage 1 hypertension or above, with around one in twenty (5.0%) recording readings indicative of Stage 2 hypertension or hypertensive crisis.
Download the full study here.
Keep updated with everything happening in and around Microtech Group plus insights into related industry news.
